For research use only. Not for therapeutic Use.
CBR-470-1 (Cat No.: I045347) is a potent and selective small-molecule inhibitor of 6-phosphogluconate dehydrogenase (6PGD), a key enzyme in the oxidative branch of the pentose phosphate pathway. By blocking 6PGD activity, CBR-470-1 disrupts cellular redox balance and nucleotide biosynthesis, making it a valuable tool in cancer metabolism research. It has shown potential in preclinical studies to impair tumor cell proliferation by targeting metabolic vulnerabilities. CBR-470-1 is instrumental for exploring therapeutic strategies that exploit altered metabolic pathways in cancer cells.
CAS Number | 2416095-06-0 |
Molecular Formula | C14H20ClNO4S2 |
Purity | ≥95% |
Reference | [1]. Bollong MJ, et, al. A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature. 2018 Oct;562(7728):600-604. [2]. Zheng J, et, al. PGK1 inhibitor CBR-470-1 protects neuronal cells from MPP+. Aging (Albany NY). 2020 Jul 10;12(13):13388-13399. |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |